| Literature DB >> 31018033 |
Andre H St Amant1, Fengying Huang2, Jia Lin2, Keith Rickert2, Vaheh Oganesyan2, Daniel Lemen2, Shenlan Mao3, Jay Harper3, Marcello Marelli2, Herren Wu2, Changshou Gao2, Javier Read de Alaniz1, R James Christie2.
Abstract
Here, we describe a diene-containing noncanonical amino acid (ncAA) capable of undergoing fast and selective normal electron-demand Diels-Alder (DA) reactions following its incorporation into antibodies. A cyclopentadiene derivative of lysine (CpHK) served as the reactive handle for DA transformations and the substrate for genetic incorporation. CpHK incorporated into antibodies with high efficiency and was available for maleimide conjugation or self-reaction depending on position in the amino acid sequence. CpHK at position K274 reacted with the maleimide drug-linker AZ1508 at a rate of ≈79 m-1 s-1 to produce functional antibody-drug conjugates (ADCs) in a one-step process. Incorporation of CpHK at position S239 resulted in dimerization, which covalently linked antibody heavy chains together. The diene ncAA described here is capable of producing therapeutic protein conjugates with clinically validated and widely available maleimide compounds, while also enabling proximity-based stapling through a DA dimerization reaction.Entities:
Keywords: Diels-Alder reaction; antibody-drug conjugate; diene; non-canonical amino acid; proximity-driven reaction
Year: 2019 PMID: 31018033 PMCID: PMC6555655 DOI: 10.1002/anie.201903494
Source DB: PubMed Journal: Angew Chem Int Ed Engl ISSN: 1433-7851 Impact factor: 15.336